Purespring Therapeutics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Rolling Stock Yard 188 York Way, London,...Phone Number
+44 2038556324Website
www.purespringtx.comRevenue
$15.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Purespring Therapeutics
Founded in 2020 and headquartered in London, England, Purespring Therapeutics is developing gene therapies to halt or prevent kidney disease.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Purespring Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Purespring Therapeutics
Click to see if Purespring Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Purespring Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Purespring Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Purespring Therapeutics has new funding data
Check out if Purespring Therapeutics is spiking on competitors!
Purespring Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Purespring Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Purespring Therapeutics
Find 3 more new buyers
Compare Similar Companies to Purespring Therapeutics
Compare insights from companies similar to Purespring Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Purespring Therapeutics
$15.5M
11-50
Private
$165M
2020
N/A
Company Profile Activity
Activity Insights
Purespring Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Purespring Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Purespring Therapeutics.
Purespring Therapeutics financials insights
Gather financial insights about Purespring Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$60M
2024
Series B
$105M
Purespring Therapeutics Tech Stack
A closer look at the technologies used by Purespring Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Research & Development, Compliance, Medical Research, Pharmaceuticals, Regulations
Project
Research & Development, Product Management, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Purespring Therapeutics News & Media
Purespring Therapeutics to Present at Piper Sandler’s 37th Annual Healthcare Conference
Purespring Therapeutics to Present at Piper Sandler’s 37th Annual Healthcare ConferencePurespring to present three posters at the American Society of Nephrology Kidney Week 2025
London – 4 November 2025 – Purespring Therapeutics, a precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function, today announced that it will be presenting three scientific posters at the American Society of Nephrology (ASN) Kidney Week 2025, held from November 5–9, 2025, in Houston, Texas.Chromatin Bioscience Announces Collaboration with Purespring Therapeutics
EDINBURGH, Scotland, Oct. 27, 2025 /PRNewswire/ -- Chromatin Bioscience is pleased to announce an ongoing research collaboration with Purespring Therapeutics, a precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function....Chromatin Bioscience Announces Collaboration with Purespring Therapeutics
EDINBURGH, Scotland, Oct. 27, 2025 /PRNewswire/ -- Chromatin Bioscience is pleased to announce an ongoing research collaboration with Purespring Therapeutics, a precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function....
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Purespring Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2020 and headquartered in London, England, Purespring Therapeutics is developing gene therapies to halt or prevent kidney disease.... Read More
